» Articles » PMID: 27512223

Relation Between the Development of Osteoporosis and Osteonecrosis Following Glucocorticoid in a Rabbit Model

Overview
Journal Indian J Orthop
Publisher Springer Nature
Specialty Orthopedics
Date 2016 Aug 12
PMID 27512223
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Background: There has been a recent increase in the number of patients suffering from bone and joint diseases, as a consequence of corticosteroids administration. There are more patients treated with low dose of GCs under long-term conditions in clinical, such as effect of GCs on Rheumatoid arthritis, Crohn's disease and Asthma patients. Hence, it was difficult for doctor to determine which problem occur first - OP or ON; however, there was no clinical report previously in the literature, and there was no effective animal model of OP and ON about low dose GCs. This study was conducted to develop rabbit models of glucocorticoid (GC)-induced femoral head ON and OP and to investigate the temporal relationship between the occurrence of the two events following administration of glucocorticoids.

Materials And Methods: Fifty six, 6 months old female rabbits were randomly divided into the GC group and control group (C). Rabbits received gluteal injections of methylprednisolone sodium succinate once a day for 4 weeks, while normal saline solution in the control group. Rabbits were sacrificed at 0, 2, 4, and 8 weeks. Hip magnetic resonance imaging was performed before the rabbits were sacrificed. Serum calcium (Ca), phosphorus (P), total cholesterol, and triglyceride levels were also measured. The bone mineral density (BMD) of femoral head and the femoral shaft were measured by dual-energy X-ray absorptiometry. The trabecular parameters of the femur and the 4(th) lumbar vertebrae (L4) were measured with a micro-computed tomography (μ-CT). Also, the femoral head was stained with hematoxylin-eosin staining.

Results: At 4 weeks in the GC group, the BMD of the femur reduced 33% and 22% in the femoral head and shaft; there was irregular intermediate to high T2-weighted images signals; μ-CT showed microfractures and cystic changes in the femoral head and L4 at 4 weeks. At 8 weeks in the GC group, the classical "line-like sign" indicating ON of the femoral head was observed in 64.3% of the rabbits.

Conclusion: A rabbit model of GC-induced OP and ON was developed by repetitive injection with small doses of GCs in the gluteal region. OP was observed at 4 weeks while ON developed at 8 weeks and followed a clear temporal pattern.

Citing Articles

Clinical Characteristics, Current Treatment Options, Potential Mechanisms, Biomarkers, and Therapeutic Targets in Avascular Necrosis of Femoral Head.

Khanchandani P, Narayanan A, Naik A, Kannan V, Pradhan S, Srimadh Bhagavatham S Med Princ Pract. 2024; 33(6):519-536.

PMID: 39168116 PMC: 11631174. DOI: 10.1159/000541044.


Osteoporosis Due to Hormone Imbalance: An Overview of the Effects of Estrogen Deficiency and Glucocorticoid Overuse on Bone Turnover.

Cheng C, Chen L, Chen K Int J Mol Sci. 2022; 23(3).

PMID: 35163300 PMC: 8836058. DOI: 10.3390/ijms23031376.


Bone-strengthening supplement (BSP) promotes bone and cartilage repair, for the treatment of Osteonecrosis of Femoral Head: an MRI-based study.

Li Z, Wei J, Xiao H, Zhu L, Weng X, Jin J Am J Transl Res. 2020; 11(12):7449-7455.

PMID: 31934292 PMC: 6943448.


Strain-specific differences in the development of bone loss and incidence of osteonecrosis following glucocorticoid treatment in two different mouse strains.

Shidara K, Mohan G, Evan Lay Y, Jepsen K, Yao W, Lane N J Orthop Translat. 2019; 16:91-101.

PMID: 30723686 PMC: 6350024. DOI: 10.1016/j.jot.2018.07.001.


Bone-strengthening pill (BSP) promotes bone cell and chondrocyte repair, and the clinical and experimental study of BSP in the treatment of osteonecrosis of the femoral head.

Li Z, Wang L, Wei J, Zhu L, Weng X, Jin J Oncotarget. 2017; 8(57):97079-97089.

PMID: 29228594 PMC: 5722546. DOI: 10.18632/oncotarget.21226.

References
1.
McKay L, Cidlowski J . CBP (CREB binding protein) integrates NF-kappaB (nuclear factor-kappaB) and glucocorticoid receptor physical interactions and antagonism. Mol Endocrinol. 2000; 14(8):1222-34. DOI: 10.1210/mend.14.8.0506. View

2.
Baofeng L, Zhi Y, Bei C, Guolin M, Qingshui Y, Jian L . Characterization of a rabbit osteoporosis model induced by ovariectomy and glucocorticoid. Acta Orthop. 2010; 81(3):396-401. PMC: 2876847. DOI: 10.3109/17453674.2010.483986. View

3.
Fessel W, Chau Q, Leong D . Association of osteonecrosis and osteoporosis in HIV-1-infected patients. AIDS. 2011; 25(15):1877-80. DOI: 10.1097/QAD.0b013e32834af637. View

4.
McIlwain H . Glucocorticoid-induced osteoporosis: pathogenesis, diagnosis, and management. Prev Med. 2003; 36(2):243-9. DOI: 10.1016/s0091-7435(02)00019-1. View

5.
Tan G, Kang P, Pei F . Glucocorticoids affect the metabolism of bone marrow stromal cells and lead to osteonecrosis of the femoral head: a review. Chin Med J (Engl). 2012; 125(1):134-9. View